353 related articles for article (PubMed ID: 28045028)
21. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation.
Li J; Cai H; Sun H; Qu J; Zhao B; Hu X; Li W; Qian Z; Yu X; Kang F; Wang W; Zou Z; Gu B; Xu K
J Ethnopharmacol; 2020 Oct; 260():112969. PubMed ID: 32422358
[TBL] [Abstract][Full Text] [Related]
22. 5, 7, 2', 4', 5'-Pentamethoxyflavanone regulates M1/M2 macrophage phenotype and protects the septic mice.
Feng LL; Xu LS; Guo MM; Huang W; Zhu JZ; Kong LD; Wu XD; Xu Q
Chin J Nat Med; 2019 May; 17(5):363-371. PubMed ID: 31171271
[TBL] [Abstract][Full Text] [Related]
23. HGF-MET Signaling Shifts M1 Macrophages Toward an M2-Like Phenotype Through PI3K-Mediated Induction of Arginase-1 Expression.
Nishikoba N; Kumagai K; Kanmura S; Nakamura Y; Ono M; Eguchi H; Kamibayashiyama T; Oda K; Mawatari S; Tanoue S; Hashimoto S; Tsubouchi H; Ido A
Front Immunol; 2020; 11():2135. PubMed ID: 32983173
[No Abstract] [Full Text] [Related]
24. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers.
Sierra-Filardi E; Puig-Kröger A; Blanco FJ; Nieto C; Bragado R; Palomero MI; Bernabéu C; Vega MA; Corbí AL
Blood; 2011 May; 117(19):5092-101. PubMed ID: 21389328
[TBL] [Abstract][Full Text] [Related]
25. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization.
Li L; Zhang HY; Zhong XQ; Lu Y; Wei J; Li L; Chen H; Lu C; Han L
Life Sci; 2020 Feb; 243():117231. PubMed ID: 31887296
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization.
Domínguez-Soto A; de las Casas-Engel M; Bragado R; Medina-Echeverz J; Aragoneses-Fenoll L; Martín-Gayo E; van Rooijen N; Berraondo P; Toribio ML; Moro MA; Cuartero I; Castrillo A; Sancho D; Sánchez-Torres C; Bruhns P; Sánchez-Ramón S; Corbí AL
J Immunol; 2014 Nov; 193(10):5181-9. PubMed ID: 25326025
[TBL] [Abstract][Full Text] [Related]
27. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.
Abumaree MH; Al Jumah MA; Kalionis B; Jawdat D; Al Khaldi A; Abomaray FM; Fatani AS; Chamley LW; Knawy BA
Stem Cell Rev Rep; 2013 Oct; 9(5):620-41. PubMed ID: 23812784
[TBL] [Abstract][Full Text] [Related]
28. C16, a novel sinomenine derivatives, promoted macrophage reprogramming toward M2-like phenotype and protected mice from endotoxemia.
Ni P; Liu YQ; Man JY; Li W; Xue SS; Lu TH; Su ZL; Zhou CL
Int J Immunopathol Pharmacol; 2021; 35():20587384211026786. PubMed ID: 34190613
[TBL] [Abstract][Full Text] [Related]
29. Anti-metastatic effects of AGS-30 on breast cancer through the inhibition of M2-like macrophage polarization.
Li J; Liu Z; Wu X; Lee SM; Seto SW; Zhang J; Zhou GC; Leung GP
Biomed Pharmacother; 2024 Mar; 172():116269. PubMed ID: 38367549
[TBL] [Abstract][Full Text] [Related]
30. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.
Hofkens W; Schelbergen R; Storm G; van den Berg WB; van Lent PL
PLoS One; 2013; 8(2):e54016. PubMed ID: 23468840
[TBL] [Abstract][Full Text] [Related]
31. Carbon Monoxide-Releasing Molecule-3 Regulates the Polarization of Lipopolysaccharide-Induced Macrophages.
Liu T; Han Q; Pan Y; Li J; Song H
Inflammation; 2021 Oct; 44(5):1737-1749. PubMed ID: 33751324
[TBL] [Abstract][Full Text] [Related]
32. Sunitinib suppresses M2 polarization of macrophages in tumor microenvironment to regulate hepatocellular carcinoma progression.
Kong Y; Guo L
J Biochem Mol Toxicol; 2023 Jun; 37(6):e23333. PubMed ID: 36797997
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway.
Lin YH; Wang YH; Peng YJ; Liu FC; Lin GJ; Huang SH; Sytwu HK; Cheng CP
Cells; 2020 Apr; 9(4):. PubMed ID: 32290250
[TBL] [Abstract][Full Text] [Related]
34. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
[TBL] [Abstract][Full Text] [Related]
35. Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors.
Hsu SPC; Chen YC; Chiang HC; Huang YC; Huang CC; Wang HE; Wang YS; Chi KH
J Neurooncol; 2020 Feb; 146(3):417-426. PubMed ID: 32020472
[TBL] [Abstract][Full Text] [Related]
36. Luteolin Alters Macrophage Polarization to Inhibit Inflammation.
Wang S; Cao M; Xu S; Shi J; Mao X; Yao X; Liu C
Inflammation; 2020 Feb; 43(1):95-108. PubMed ID: 31673976
[TBL] [Abstract][Full Text] [Related]
37. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
[TBL] [Abstract][Full Text] [Related]
38. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
Gong M; Zhuo X; Ma A
Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
[TBL] [Abstract][Full Text] [Related]
39. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
40. An in vitro test system for compounds that modulate human inflammatory macrophage polarization.
Shiratori H; Feinweber C; Luckhardt S; Wallner N; Geisslinger G; Weigert A; Parnham MJ
Eur J Pharmacol; 2018 Aug; 833():328-338. PubMed ID: 29920284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
